UCLA HF Guideline

The ACC/AHA guidelines recommend using only those beta blockers and those doses that have been proven to reduce mortality (i.e. mortality reduction is not a class effect). COMET demonstrated that carvedilol (beta-1, beta-2, and alpha-1 blockade) provided a 17% mortality reduction compared to beta-1 selective blockade with metoprolol tartrate. ................
................